Skip to main content
Checking gut microbiome in cirrhosis may prevent readmission
2/12/2020

Evaluating changes to the gut microbiome in patients with cirrhosis identified potential problems and reduced the likelihood the patient would be readmitted, according to a study led by Jasmohan Bajaj, MD, a professor of medicine at Virginia Commonwealth University, that was published in GastroHep. The study used tests ranging from $250 to $650 and found that the more expensive tests resulted in the most overall cost savings.

Full Story: